BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 23967098)

  • 21. Impact of Chemoembolic Regimen on Immune Cell Recruitment and Immune Checkpoint Marker Expression following Transcatheter Arterial Chemoembolization in a VX2 Rabbit Liver Tumor Model.
    Berz AM; Santana JG; Iseke S; Gross M; Pekurovsky V; Laage Gaupp F; Savic LJ; Borde T; Gottwald LA; Boustani AM; Gebauer B; Lin M; Zhang X; Schlachter T; Madoff DC; Chapiro J
    J Vasc Interv Radiol; 2022 Jul; 33(7):764-774.e4. PubMed ID: 35346859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatic arterial administration of sorafenib and iodized oil effectively attenuates tumor growth and intrahepatic metastasis in rabbit VX2 hepatocellular carcinoma model.
    Zhang L; Liu FY; Fu JX; Duan F; Fan QS; Wang MQ
    Int J Clin Exp Pathol; 2014; 7(11):7775-81. PubMed ID: 25550815
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three treatment methods via the hepatic artery for hepatocellular carcinoma - a retrospective study.
    Ma TC; Shao HB; Xu Y; Xu K
    Asian Pac J Cancer Prev; 2013; 14(4):2491-4. PubMed ID: 23725162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transarterial (chemo)embolisation versus no intervention or placebo for liver metastases.
    Swierz MJ; Storman D; Riemsma RP; Wolff R; Mitus JW; Pedziwiatr M; Kleijnen J; Bala MM
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009498. PubMed ID: 32163181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nitroglycerine use in transcatheter arterial (chemo)embolization in patients with hepatocellular carcinoma and dual-energy CT assessment of Lipiodol retention.
    Liu YS; Chuang MT; Tsai YS; Tsai HM; Lin XZ
    Eur Radiol; 2012 Oct; 22(10):2193-200. PubMed ID: 22618520
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Diagnostic value of computed tomographic perfusion imaging of whole liver for quantitative assessment of blood flow state in liver cancer after transcatheter arterial chemoembolization].
    Li SM; Gao ZL; Lyu XT; Jia J; Zhu P; Chen Y; Liu YL; Zhang ZX
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jun; 26(6):429-435. PubMed ID: 30317756
    [No Abstract]   [Full Text] [Related]  

  • 27. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
    Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
    Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model.
    Gupta S; Kobayashi S; Phongkitkarun S; Broemeling LD; Kan Z
    Invest Radiol; 2006 Jun; 41(6):516-21. PubMed ID: 16763470
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of damage to liver function after TACE with use of low-dose versus conventional-dose of anticancer drugs in hepatocellular carcinoma.
    Lu W; Li YH; Yu ZJ; He XF; Chen Y; Zhao JB; Zhu ZY
    Hepatogastroenterology; 2007; 54(77):1499-502. PubMed ID: 17708284
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic damage induced by transcatheter arterial chemoembolization elevates serum concentrations of macrophage-colony stimulating factor.
    Itoh Y; Okanoue T; Ohnishi N; Nishioji K; Sakamoto S; Nagao Y; Nakamura H; Kirishima T; Kashima K
    Liver; 1999 Apr; 19(2):97-103. PubMed ID: 10220738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and Safety of Lenvatinib-Transcatheter Arterial Chemoembolization Sequential Therapy for Patients with Intermediate-Stage Hepatocellular Carcinoma.
    Ando Y; Kawaoka T; Amioka K; Naruto K; Ogawa Y; Yoshikawa Y; Kikukawa C; Kosaka Y; Uchikawa S; Morio K; Fujino H; Nakahara T; Murakami E; Yamauchi M; Tsuge M; Hiramatsu A; Fukuhara T; Mori N; Takaki S; Tsuji K; Nonaka M; Hyogo H; Aisaka Y; Masaki K; Honda Y; Moriya T; Naeshiro N; Takahashi S; Imamura M; Chayama K; Aikata H
    Oncology; 2021; 99(8):507-517. PubMed ID: 33946070
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic arterial damage after transarterial chemoembolization for the treatment of hepatocellular carcinoma: comparison of drug-eluting bead and conventional chemoembolization in a retrospective controlled study.
    Lee S; Kim KM; Lee SJ; Lee KH; Lee DY; Kim MD; Kim DY; Kim SU; Won JY
    Acta Radiol; 2017 Feb; 58(2):131-139. PubMed ID: 27217418
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemoembolization of liver cancer with doxorubicin-loaded CalliSpheres microspheres: plasma pharmacokinetics, intratumoral drug concentration, and tumor necrosis in a rabbit model.
    Liang B; Zhao D; Liu Y; Guo X; Zhang H; Zhang L; Zheng C
    Drug Deliv Transl Res; 2020 Feb; 10(1):185-191. PubMed ID: 31482517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sequential transcatheter arterial chemoembolization and portal vein embolization before right hemihepatectomy in patients with hepatocellular carcinoma.
    Park GC; Lee SG; Yoon YI; Sung KB; Ko GY; Gwon DI; Jung DH; Jung YK
    Hepatobiliary Pancreat Dis Int; 2020 Jun; 19(3):244-251. PubMed ID: 32414576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transarterial injection of (131)I-lipiodol, compared with chemoembolization, in the treatment of unresectable hepatocellular cancer.
    Marelli L; Shusang V; Buscombe JR; Cholongitas E; Stigliano R; Davies N; Tibballs J; Patch D; Meyer T; Burroughs AK
    J Nucl Med; 2009 Jun; 50(6):871-7. PubMed ID: 19443599
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A small interfering RNA targeting vascular endothelial growth factor efficiently inhibits growth of VX2 cells and VX2 tumor model of hepatocellular carcinoma in rabbit by transarterial embolization-mediated siRNA delivery.
    Zou Y; Guo CG; Yang ZG; Sun JH; Zhang MM; Fu CY
    Drug Des Devel Ther; 2016; 10():1243-55. PubMed ID: 27069355
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
    Deng G; Zhao DL; Li GC; Yu H; Teng GJ
    Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Histopathological changes in rabbit uterus carcinoma after transcatheter arterial embolization using cisplatin.
    Harima Y; Harima K; Hasegawa T; Shikata N; Tanaka Y
    Cancer Chemother Pharmacol; 1996; 38(4):317-22. PubMed ID: 8674153
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of hepatic artery embolization on liver hypertrophy response in a rabbit liver VX2 tumor model.
    van Lienden KP; Hoekstra LT; van Trigt JD; Roelofs JJ; van Delden OM; van Gulik TM
    Hepatobiliary Pancreat Dis Int; 2013 Dec; 12(6):622-9. PubMed ID: 24322748
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiogenesis in rabbit hepatic tumor after transcatheter arterial embolization.
    Liao XF; Yi JL; Li XR; Deng W; Yang ZF; Tian G
    World J Gastroenterol; 2004 Jul; 10(13):1885-9. PubMed ID: 15222029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.